Details of the Drug Reposition

General Information of This Drug (ID: DMXU2D1)

Drug Name
CAR-CD19 T cell   DMXU2D1
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Clinical trial Indication(s)
Indication Name Indication ID ICD-11 Status REF
leukaemia DISS7D1V 2A60-2B33 Clinical trial [1]
B-cell lymphoma DISIH1YQ 2A86 Clinical trial [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03302403) Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors